$129.090
+0.439 (+0.34%)收盘时
MLAB 资讯
MLAB 事件
Mesa Q1 Revenue at $60.14M, Below Consensus
Reports Q1 revenue $60.14M, consensus $60.87M. "I joined Mesa about one hundred days ago. I did not spend my time writing a vision statement, I spent it inside the company, with our people and our customers. What I found is a set of durable, regulation-embedded franchises with real and growing earnings power, and fixable execution problems we have already begun to fix. My focus is disciplined execution and consistent, profitable growth across our four divisions. In November, alongside first-half results, I will give full-year guidance," said Siddhartha Kadia, President and CEO of Mesa.
Mesa Q1 Revenue at $63.72M, Below Consensus
Reports Q1 revenue $63.72M, consensus $65.2M. "As announced in March, I am in the middle of my onboarding journey as I am conducting my first 100 days review of the businesses since joining Mesa on April 13. I want to share that I am even more excited today than the day I joined. The Mesa diversified platform has tremendous potential to create shareholder value while delivering on our promise to Protect the Vulnerable. Upon completion of my 100-day review of our business, I am looking forward to begin meeting with our shareholders and discussing my vision for the Company moving forward. I also expect to be in position to provide rest of the year guidance along with the release of H1 results," said Siddhartha Kadia, president and CEO of Mesa.
Mesa Labs Appoints Siddhartha Kadia as New CEO
Mesa Labs announced that Gary Owens will step down as president and CEO on April 12 and will enable a leadership transition. To lead the company's next chapter, the board of directors has appointed Siddhartha Kadia as president and CEO, effective April 13. Kadia will also join the board. Kadia most recently served as CEO of Calibre Scientific.
Mesa Reports Q3 Revenue of $65.126M, Beating Consensus
Reports Q3 revenue $65.126M, consensus $63.23M. "Steady execution and relatively stable markets across Europe and North America helped deliver 3.6% organic revenues growth in 3Q26 versus the prior year, or 5.7% when excluding CG China revenues. Total company growth was 7.2% sequentially, well within our expected growth range. Strong growth in BPD, continued growth in CG excluding China, and a recovery towards normal SDC deliveries overcame strong but expected headwinds in CG China. For the first nine months of FY26, we delivered 3.7% organic revenues growth, but 6.6% when excluding CG China revenues. With continued strong execution across the business and less impactful CG China compares moving forward, we expect our positive momentum to continue in 4Q26" said Gary Owens, Chief Executive Officer of Mesa.
Mesa Labs announces Q2 earnings per share of 45 cents, down from 63 cents a year ago.
Reports Q2 revenue $60.7M vs. $57.83M last year. The company said, "Solid execution and market stability across Europe and North America helped deliver 5.0% organic (3.7% core organic) revenue growth in 2Q26 versus the prior year. BPD growth, aided by delayed bookings from 1Q26, continued strength in CS, and double-digit growth in CG excluding China overcame softness in SDC deliveries and strong but expected headwinds in CG China (58% decrease versus prior year). Despite macroeconomic uncertainty, we delivered strong growth of 3.7% organic over the first half of FY26, and we expect revenues to sequentially increase in 3Q26."
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。